KUALA LUMPUR, Aug 7 (Bernama) -- Pharmanovia, a global pharmaceutical company has appointed YongSeok Choi, who will take the role of General Manager for Korea and Japan.
In his new role, Choi will be based in Korea and will work closely with Pharmanovia’s global and regional teams, as well as partners in Korea and Japan, to drive the company’s growth and identify new business development opportunities.
“We are thrilled to welcome YongSeok to the Pharmanovia team. His strategic acumen and expertise within the field of innovative medicines will be fundamental as we look to expand our reach within APAC.
“We are confident that YongSeok's leadership and knowledge of these key markets will further strengthen our position as a speciality pharmaceutical company,” said Its Vice President, APAC, Dimitri Pimbert in a statement.
Meanwhile, Choi said: “I am honoured to lead the charge in growing our Korean operations and building out our presence and capabilities in Japan, where I am confident that we can make a significant impact on patients' lives.
“I look forward to working with Pharmanovia’s global and regional leaders and teams to seize opportunities in this dynamic, promising space.”
With an impressive career spanning over 24 years within the pharmaceutical and biotechnology industry, Choi brings an extensive breadth of knowledge and experience in strategy, business management and operations, and product development.
Before joining Pharmanovia, he was the Chief Executive Officer of BioGraphene Inc, a biotech start-up focused on new drug development for neurodegenerative disorders, and holds a Bachelor of Science in Life Science and Master of Science in Environmental Engineering from POSTECH, Korea.
A global lifecycle management healthcare company, Pharmanovia commercialises novel medicines and revitalises, extends and expands the lifecycle of established medicines.
-- BERNAMA
No comments:
Post a Comment